Results 151 to 160 of about 2,561,087 (298)
Molecular Oncology, EarlyView.Plasma‐based detection of actionable mutations is a promising approach in lung cancer management. Analysis of ctDNA with a multigene NGS panel identified TP53, KRAS, and EGFR as the most frequently altered, with TP53 and KRAS in treatment‐naïve patients and TP53 and EGFR in previously treated patients.
Giovanna Maria Stanfoca Casagrande +11 more
wiley +1 more source
Impact Factor Insights 2025: Analysis of Pakistani Academic Journals. [PDF]
Pak J Med SciMeo SA, Jawaid SA.
europepmc +1 more source
An Impact Factor for Neuro-Oncology Practice. [PDF]
Neurooncol Pract, 2023 Taphoorn MJB.
europepmc +1 more source
Aggressive prostate cancer is associated with pericyte dysfunction
Molecular Oncology, EarlyView.Tumor‐produced TGF‐β drives pericyte dysfunction in prostate cancer. This dysfunction is characterized by downregulation of some canonical pericyte markers (i.e., DES, CSPG4, and ACTA2) while maintaining the expression of others (i.e., PDGFRB, NOTCH3, and RGS5).
Anabel Martinez‐Romero +11 more
wiley +1 more source
Recent Trends and Expectations of Progress in Rehabilitation Medicine: Celebrating the First Impact Factor. [PDF]
Prog Rehabil MedMomosaki R.
europepmc +1 more source
Molecular Oncology, EarlyView.ERRFI1, a neural crest (NC)‐associated gene, was upregulated in melanoma and negatively correlated with the expression of melanocytic differentiation markers and the susceptibility of melanoma cells toward BRAF inhibitors (BRAFi). Knocking down ERRFI1 significantly increased the sensitivity of melanoma cells to BRAFi.
Nina Wang +8 more
wiley +1 more source
A pilot study investigating the relationship between journal impact factor and methodological quality of real-world observational studies. [PDF]
Front Res Metr AnalGupta D, Kaur A, Malik M.
europepmc +1 more source